Prophylaxis of chemotherapy-induced neutropenia with lipegfilgrastim in patients with lung cancer: final results from the non-interventional study NADIR
Article in Current Medical Research and Opinion (September 2022)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
A multinational, drug utilization study of lipegfilgrastim use in real-world setting in Europe
Article in Supportive Care in Cancer (August 2022)
rhG-CSF is associated with an increased risk of metastasis in NSCLC patients following postoperative chemotherapy
Article in BMC Cancer (July 2022)